CDC20 and hepatocellular carcinoma: Furthermore, as the tumor status changed with treatment, the expression levels of these genes changed correspondingly in PBMCs; treated HCC patients without active/residual tumor cells had higher transcript levels of CCNB1, CDC20, and CENPF compared with the other two subgroups of HCC patients (Figure 3A).